Results 211 to 220 of about 21,425 (243)
Some of the next articles are maybe not open access.

Autoimmune hemolytic anemia

Human Pathology, 1983
Nowhere in the management of patients with autoimmune hemolytic anemias is the communication between clinician and laboratory personnel more important than in regard to blood transfusion. A clinical decision that blood transfusion is necessary must be tempered by the knowledge that transfusion has a greater-than-usual risk in this setting, both because
openaire   +2 more sources

Geoepidemiology of autoimmune hemolytic anemia

Autoimmunity Reviews, 2010
Autoantibodies against red blood cell antigens are considered the diagnostic hallmark of AIHA: Direct antiglobulin test (DAT) completed by cytofluorometry and specific diagnostic monoclonal antibodies (mAbs) allow for a better understanding of autoimmune hemolytic anemia (AIHA) triggers. Once B-cell tolerance checkpoints are bypassed, the patient loses
Jean-Francois, Lambert, Urs E, Nydegger
openaire   +2 more sources

Autoimmune Hemolytic Anemia in a Dog

Journal of the American Veterinary Medical Association, 1973
SUMMARY Autoimmune hemolytic anemia (aha) occurred in a 3½-year-old Cocker Spaniel. The clinical signs and blood values on initial examination were consistent with a diagnosis of aha; however, the results of Coombs’ antiglobulin test were not conclusive until 7 months later.
M D, Avolt, J E, Lund, J C, Pickett
openaire   +2 more sources

Treatment of Autoimmune Hemolytic Anemia

Seminars in Hematology, 2005
The appropriate therapy of autoimmune hemolytic anemia (AIHA) is dependent on the correct diagnosis and classification of this family of hemolytic disorders. Although the majority of cases are warm AIHA, there are several distinct types of cold AIHA and a number of drug-induced etiologies of AIHA, which must be investigated to determine if stopping a ...
Karen E, King, Paul M, Ness
openaire   +2 more sources

Autoimmune Hemolytic Anemia and Cancer

JAMA: The Journal of the American Medical Association, 1965
THE OCCURRENCE of overt hemolytic anemia in malignant diseases other than those involving the reticuloendothelial system is uncommon. Approximately 15 cases of overt hemolytic anemia associated with cancer have been reported in the medical literature.
L D, ELLIS, M P, WESTERMAN
openaire   +2 more sources

Warm Autoimmune Hemolytic Anemia

Hematology/Oncology Clinics of North America, 2015
Warm autoimmune hemolytic anemia (AIHA) is defined as the destruction of circulating red blood cells (RBCs) in the setting of anti-RBC autoantibodies that optimally react at 37°C. The pathophysiology of disease involves phagocytosis of autoantibody-coated RBCs in the spleen and complement-mediated hemolysis.
openaire   +2 more sources

Treatment of autoimmune hemolytic anemias

Current Opinion in Hematology, 2001
Treatment of autoimmune hemolytic anemias varies depending on whether the patient has autoimmune hemolytic anemia of warm antibody type, cold agglutinin syndrome, paroxysmal cold hemoglobinuria, or autoimmune hemolytic anemia secondary to an underlying disorder.
openaire   +2 more sources

Autoimmunization and the Autoimmune Hemolytic Anemias.

Archives of Internal Medicine, 1970
Comparison is inevitable with part 2 of The Haemolytic Anaemias: The Autoimmune Haemolytic Anaemias , 1962, by John Dacie which, as they say in show biz, is a tough act to follow. Dacie brought to his task the long experience of a gifted and methodical hematologist.
openaire   +2 more sources

Autoimmune Hemolytic Anemia: A Review

American Journal of Clinical Pathology, 1971
Autoimmune hemolytic anemia (AIHA) represents the most elegant model of autoimmunity in humans. It is frequently associated with other diseases of altered immune states. By definition, antibody must be demonstrable in every case. Two types of antibody, cold and warm, are recognized.
openaire   +2 more sources

Autoimmunization and the Autoimmune Hemolytic Anemias

JAMA: The Journal of the American Medical Association, 1969
This is an unusual book in both concept and presentation. The first half presents the problem of autoimmune hemolytic anemias in a clinical perspective. Material from the vast literature is interwoven with a very substantial personal clinical experience, more than 200 cases, that the author observed during an eight-year period.
openaire   +1 more source

Home - About - Disclaimer - Privacy